Related Experiment Video
Updated: May 25, 2026
14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods
Journal of Ocular Biology, Diseases, and Informatics
|February 10, 2012
Summary
Paraoxonase (PON) enzymes, including PON1 and PON2, are crucial for health. This study modeled PON2, revealing shared and distinct ligand interactions compared to PON1, with PON2 showing higher affinity for homocysteine thiolactone.
Area of Science:
- Biochemistry
- Enzymology
- Structural Biology
Background:
- Paraoxonase (PON) enzymes (PON1, PON2, PON3) are calcium-dependent mammalian enzymes with arylesterase, lactonase, and paraoxonase activities.
- Reduced PON activity is linked to cardiovascular disease, atherosclerosis, and diabetes.
- While PON1 has been studied in silico, PON2, the oldest family member, lacks similar computational investigation.
Purpose of the Study:
- To computationally model the structure of the PON2 enzyme.
- To investigate the in silico interactions of PON2 with relevant ligands and its physiological substrate, homocysteine thiolactone (HCTL).
- To compare ligand binding patterns of PON2 with those of PON1.
Main Methods:
- Protein structure modeling using MODELLER 9v7.
- Molecular docking simulations using AutoDock 4.0 to analyze ligand-enzyme interactions.
- Comparative analysis of binding affinities and interaction patterns between PON1 and PON2.
Main Results:
- PON1 and PON2 exhibit similar ligand binding patterns for arylesterase and lactonase activities.
- Distinct amino acid residues are involved in paraoxon binding between PON1 and PON2.
- Homocysteine thiolactone (HCTL) demonstrated the lowest binding free energy (ΔG) and highest affinity for PON2 compared to PON1.
Conclusions:
- PON2 shares common ligand binding characteristics with PON1 but possesses unique interaction sites for specific substrates like paraoxon.
- The higher binding affinity of HCTL for PON2 suggests a potentially significant role in its physiological function.
- In silico modeling provides valuable insights into the structural and functional differences between PON family members, aiding future drug design and therapeutic strategies.
Related Concept Videos
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...